Kenvue’s first quarter results have exceeded estimates thanks to the good health of the personal care unit.

Kenvue Inc. is one of the world leaders in the design, manufacturing and marketing of consumer health products. The group offers health, beauty, baby care, oral care, skin care, etc. The CA by family of products is distributed as follows: – Self -medication products (41.8%): intended for the treatment of cough, colds, allergies, pain, indigestion, constipation, etc. (Marques Zyrtec, Benadryl, Zarbee’s, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); -Personal care products (29.9%): in particular oral care products, baby care, female health and wound treatment (Listrine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin, etc.); – Beauty and skin care products (28.3%): hair products, sun protection, facial and body care, etc. (Marques Neutrogena, Aveeno, Clean & Clear, Lubriderm, Johnsons, Neostrata, Ogx, Rogaine, etc.). The marketing of products is ensured through direct sales, through distributors and via the Internet. The geographical distribution of the CA is as follows: North America (49.3%), Europe-Midor Orient-Africa (21.9%), Asia-Pacific (20.1%) and Latin America (8.7%).